[EN] DIHYDROMYRICETIN FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE GLUTAMATERGIC SYSTEM<br/>[FR] DIHYDROMYRICÉTINE POUR LE TRAITEMENT DE MALADIES ET DE TROUBLES DU SYSTÈME GLUTAMATERGIQUE
申请人:UNIV CALIFORNIA
公开号:WO2014007853A1
公开(公告)日:2014-01-09
Disclosed herein are methods and compositions for treating a disease or disorder of the glutamatergic system, e.g., Alzheimer's disease, neuron damage and/or loss, and seizures, or a symptom thereof, e.g., decreased cognitive function, in a subject which comprises administering dihydromyricetin (DHM), an analog of DHM, or a metabolite of DHM to the subject.